These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Giancane G; Ter Haar NM; Wulffraat N; Vastert SJ; Barron K; Hentgen V; Kallinich T; Ozdogan H; Anton J; Brogan P; Cantarini L; Frenkel J; Galeotti C; Gattorno M; Grateau G; Hofer M; Kone-Paut I; Kuemmerle-Deschner J; Lachmann HJ; Simon A; Demirkaya E; Feldman B; Uziel Y; Ozen S Ann Rheum Dis; 2015 Apr; 74(4):635-41. PubMed ID: 25628446 [TBL] [Abstract][Full Text] [Related]
43. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ter Haar N; Lachmann H; Özen S; Woo P; Uziel Y; Modesto C; Koné-Paut I; Cantarini L; Insalaco A; Neven B; Hofer M; Rigante D; Al-Mayouf S; Touitou I; Gallizzi R; Papadopoulou-Alataki E; Martino S; Kuemmerle-Deschner J; Obici L; Iagaru N; Simon A; Nielsen S; Martini A; Ruperto N; Gattorno M; Frenkel J; Ann Rheum Dis; 2013 May; 72(5):678-85. PubMed ID: 22753383 [TBL] [Abstract][Full Text] [Related]
44. Familial mediterranean Fever in the world. Ben-Chetrit E; Touitou I Arthritis Rheum; 2009 Oct; 61(10):1447-53. PubMed ID: 19790133 [No Abstract] [Full Text] [Related]
45. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Pras E; Livneh A; Balow JE; Pras E; Kastner DL; Pras M; Langevitz P Am J Med Genet; 1998 Jan; 75(2):216-9. PubMed ID: 9450890 [TBL] [Abstract][Full Text] [Related]
46. Diagnosis and management of familial Mediterranean fever: integrating medical genetics in a dedicated interdisciplinary clinic. Zadeh N; Getzug T; Grody WW Genet Med; 2011 Mar; 13(3):263-9. PubMed ID: 21317656 [TBL] [Abstract][Full Text] [Related]
47. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. van der Hilst JCH; Bodar EJ; Barron KS; Frenkel J; Drenth JPH; van der Meer JWM; Simon A; Medicine (Baltimore); 2008 Nov; 87(6):301-310. PubMed ID: 19011501 [TBL] [Abstract][Full Text] [Related]
48. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. van der Meer JW; Vossen JM; Radl J; van Nieuwkoop JA; Meyer CJ; Lobatto S; van Furth R Lancet; 1984 May; 1(8386):1087-90. PubMed ID: 6144826 [TBL] [Abstract][Full Text] [Related]
49. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). Demirkaya E; Acikel C; Hashkes P; Gattorno M; Gul A; Ozdogan H; Turker T; Karadag O; Livneh A; Ben-Chetrit E; Ozen S; Ann Rheum Dis; 2016 Jun; 75(6):1051-6. PubMed ID: 26823530 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one? Kalkan G; Demirkaya E; Acikel CH; Polat A; Peru H; Karaoglu A; Sari E; Dursun I; Gok F; Ozen S; Rheumatology (Oxford); 2012 Apr; 51(4):743-8. PubMed ID: 22190688 [TBL] [Abstract][Full Text] [Related]
51. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries. Vitale A; Caggiano V; Tufan A; Ragab G; Batu ED; Portincasa P; Aragona E; Sota J; Conti G; De Paulis A; Rigante D; Olivieri AN; Şahin A; La Torre F; Lopalco G; Cattalini M; Maggio MC; Insalaco A; Sfikakis PP; Verrecchia E; Yildirim D; Kucuk H; Kardas RC; Laymouna AH; Ghanema M; Saad MA; Sener S; Ercan Emreol H; Ozen S; Jaber N; Khalil M; Di Ciaula A; Gaggiano C; Malizia G; Affronti A; Patroniti S; Romeo M; Sbalchiero J; Della Casa F; Mormile I; Silvaroli S; Gicchino MF; Çelik NÇ; Tarsia M; Karamanakos A; Hernández-Rodríguez J; Parronchi P; Opris-Belinski D; Barone P; Recke A; Costi S; Sfriso P; Giardini HAM; Gentileschi S; Wiesik-Szewczyk E; Vasi I; Loconte R; Jahnz-Różyk K; Martín-Nares E; Torres-Ruiz J; Cauli A; Conforti A; Emmi G; Li Gobbi F; Biasi GR; Terribili R; Ruscitti P; Del Giudice E; Tharwat S; Brucato AL; Ogunjimi B; Hinojosa-Azaola A; Balistreri A; Fabiani C; Frediani B; Cantarini L Front Immunol; 2024; 15():1397890. PubMed ID: 38799474 [TBL] [Abstract][Full Text] [Related]
52. Treat-to-target strategies for the management of familial Mediterranean Fever in children. Ehlers L; Rolfes E; Lieber M; Müller D; Lainka E; Gohar F; Klaus G; Girschick H; Hörstermann J; Kümmerle-Deschner J; Brunner J; Palm-Beden K; Tenbrock K; von Wrangel L; Faßhauer M; Blank N; Trauzeddel R; von Stuckrad ASL; Higgins S; Welzel T; Lutz T; Hentgen V; Foell D; Wittkowski H; Kallinich T Pediatr Rheumatol Online J; 2023 Sep; 21(1):108. PubMed ID: 37752496 [TBL] [Abstract][Full Text] [Related]
53. Cardiac repolarization abnormalities in children with familial Mediterranean fever. Farag Y; Sayed S; Mostafa FA; Marzouk H; Mohamed RH; Sobhy R Pediatr Rheumatol Online J; 2022 May; 20(1):38. PubMed ID: 35606812 [TBL] [Abstract][Full Text] [Related]
54. Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review. Vinit C; Georgin-Lavialle S; Theodoropoulou A; Barbier C; Belot A; Mejbri M; Pillet P; Pachlopnik J; Poignant S; Rebelle C; Woerner A; Koné-Paut I; Hentgen V Front Immunol; 2021; 12():744780. PubMed ID: 34858402 [TBL] [Abstract][Full Text] [Related]
55. Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis. Demir CF; BALGETiR F; Ethemoğlu Ö; Aksoy D; Aktaş F; Koca SS; Yetkin MF; Taşci İ Arch Rheumatol; 2021 Jun; 36(2):219-226. PubMed ID: 34527926 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of the international severity score for FMF (ISSF) scores in Turkish children diagnosed with FMF: a single-center experience. Özdemir FMA; Gülez N; Makay B Clin Rheumatol; 2021 Aug; 40(8):3219-3225. PubMed ID: 33619627 [TBL] [Abstract][Full Text] [Related]
57. [Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology]. Sahr T; Kiltz U; Weseloh C; Kallinich T; Braun J Z Rheumatol; 2020 Nov; 79(9):943-951. PubMed ID: 32997267 [TBL] [Abstract][Full Text] [Related]
58. Comparison of clinical features in FMF patients according to severity scores: An analysis with the ISSF scoring system. Yaşar Bilge NŞ; Bodakçi E; Bilgin M; Kaşifoğlu T Eur J Rheumatol; 2020 Apr; 7(2):68-70. PubMed ID: 32644926 [TBL] [Abstract][Full Text] [Related]
59. Disease Severity and Genotype Affect Physical Growth in Children With Familial Mediterranean Fever. Kişla Ekinci RM; Balci S; Akay E; Doğruel D; Altintaş DU; Yilmaz M Arch Rheumatol; 2019 Sep; 34(3):288-293. PubMed ID: 31598594 [TBL] [Abstract][Full Text] [Related]
60. Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine. Berdeli A; Şenol Ö; Talay G Eur J Rheumatol; 2019 Apr; 6(2):85-88. PubMed ID: 31365342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]